Colin Grabow One hopeful theory behind the Trump administration’s “Liberation Day” tariff increases was that they were a negotiating tool to ultimately produce a more open trade environment. The tariffs…

In this in-depth walkthrough, Grayson introduces the brand-new Market Summary Dashboard, an all-in-one resource designed to help you analyze the market with ease, speed, and depth. Follow along as Grayson…

Michael F. Cannon I’m usually the guy reminding everybody, “It is not a ‘price control’ when the government reduces the prices [it] pays for drugs.” I expected that I would…

China has agreed to ‘open itself up to American business’ following trade negotiations between Washington, D.C., and Beijing on Saturday, according to President Donald Trump. The arrangement was arguably the…

President Donald Trump defended the U.S. preparing to accept a jumbo jet gift from Qatar’s royal family to serve as a temporary Air Force One as Boeing failed to roll…

President Donald Trump declared Monday that the U.S. ‘will no longer tolerate profiteering and price gouging from Big Pharma’ as he signed an executive order implementing what his administration is…

House and Senate Republicans have been working for months on a sweeping piece of legislation addressing a litany of President Donald Trump’s agenda items. Such a bill is possible via…

Earnings season continues, and this week we’re looking at three companies heading into their reports with different trajectories. One is in a long-term downtrend, one has been a steady riser,…

Sector Shuffle: Same Players, New Positions The past week brought an unusual shake-up in the RRG sector ranking model. While the composition of the top five sectors, and thus the…

Michael F. Cannon UPDATE: The executive order President Trump signed today does in fact attempt to impose price controls on private purchases of prescription drugs. See this blog post for…